T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. (2021)
Attributed to:
Application of an in vitro cell-based system to investigate the killing of target tissue by drug-specific T-cells
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-21856-3
PubMed Identifier: 33824342
Publication URI: http://europepmc.org/abstract/MED/33824342
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723